ACADIAN ASSET MANAGEMENT LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,733
-14.4%
236,902
+5.5%
0.02%
-11.1%
Q2 2023$4,361
-28.6%
224,576
+4.2%
0.02%
-33.3%
Q1 2023$6,108
-9.7%
215,431
-7.0%
0.03%
-18.2%
Q4 2022$6,765
-99.9%
231,587
-25.6%
0.03%
-26.7%
Q3 2022$8,223,000
-1.0%
311,220
+66.5%
0.04%
+7.1%
Q2 2022$8,303,000
+20.2%
186,873
+33.8%
0.04%
+50.0%
Q1 2022$6,908,000
+28.2%
139,695
+31.9%
0.03%
+40.0%
Q4 2021$5,388,000
-25.3%
105,879
-18.2%
0.02%
-28.6%
Q3 2021$7,213,000
-35.6%
129,430
-50.5%
0.03%
-33.3%
Q2 2021$11,200,000
+26.0%
261,703
+22.9%
0.04%
+20.0%
Q1 2021$8,890,000
+11.3%
213,009
+24.2%
0.04%
+12.9%
Q4 2020$7,988,000
+11.5%
171,484
+1.7%
0.03%
+3.3%
Q3 2020$7,167,000
+26.5%
168,699
+42.9%
0.03%
+25.0%
Q2 2020$5,664,000
+39.9%
118,056
+34.1%
0.02%
+4.3%
Q1 2020$4,049,000
+185.5%
88,013
+272.9%
0.02%
+283.3%
Q4 2019$1,418,000
-17.8%
23,600
-22.6%
0.01%
-14.3%
Q3 2019$1,725,000
-11.1%
30,493
-12.6%
0.01%
-22.2%
Q2 2019$1,941,000
+824.3%
34,873
+740.7%
0.01%
+800.0%
Q1 2019$210,000
+73.6%
4,148
+37.9%
0.00%0.0%
Q4 2018$121,000
+5.2%
3,008
+82.1%
0.00%
Q3 2018$115,000
-42.8%
1,652
-56.1%
0.00%
-100.0%
Q4 2017$201,000
-55.9%
3,761
-50.8%
0.00%
-50.0%
Q3 2017$456,0007,6370.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders